Straits Research is excited to announce the latest insights into the global bioabsorbable stents market, which is expected to witness significant growth in the coming years. The market was valued at USD 970.00 million in 2023 and is projected to grow from USD 1,080.00 million in 2024 to USD 1,960.00 million by 2032, with a compound annual growth rate (CAGR) of 8.76% during the forecast period (2024–2032). This growth is being fueled by the rising prevalence of coronary and peripheral artery diseases, increasing demand for minimally invasive procedures, and advancements in bioabsorbable materials technology.
For a full PDF sample of the report, visit https://straitsresearch.com/report/bioabsorbable-stents-market/request-sample
Market Definition
Bioabsorbable stents are temporary medical devices used to treat coronary artery diseases (CAD) and peripheral artery diseases (PAD). These stents, made from biocompatible materials, provide structural support to arteries after a procedure, and then gradually dissolve over time, eliminating the need for permanent foreign objects in the body. Bioabsorbable stents are expected to offer long-term benefits over traditional metal stents by reducing the risk of complications such as restenosis and thrombosis.
Latest Market Trends
Advancements in Material Technology: Bioabsorbable stents are evolving with new materials such as polymers and metals, which allow for more controlled absorption and improved performance. Researchers are exploring biodegradable magnesium alloys, as well as natural and synthetic polymers, for more efficient stents.
Rising Demand for Minimally Invasive Procedures: Minimally invasive techniques are becoming the preferred choice for treating coronary and peripheral artery diseases, and bioabsorbable stents are perfectly aligned with this trend. These stents offer the advantage of being gradually absorbed into the body, eliminating the need for long-term post-procedure interventions.
Regulatory Advancements and Approvals: The approval of bioabsorbable stents by regulatory bodies such as the FDA and European Medicines Agency (EMA) has spurred innovation and market expansion. Continued regulatory support is expected to further fuel the growth of bioabsorbable stents worldwide.
Growth Factors Driving Market Expansion
Increasing Prevalence of Cardiovascular Diseases: The rise in lifestyle-related diseases, especially among aging populations, has led to an increase in cardiovascular conditions such as coronary artery disease (CAD) and peripheral artery disease (PAD). Bioabsorbable stents offer a promising solution for treating these conditions, contributing to the market’s growth.
Technological Advancements: Ongoing advancements in the design and materials used in bioabsorbable stents, such as the development of stents with improved mechanical properties and controlled absorption rates, are boosting the demand for these devices. Additionally, new drug-eluting stents (DES) are improving patient outcomes and reducing complications.
Growing Preference for Minimally Invasive Surgeries: There is a growing preference for minimally invasive surgeries that require shorter recovery times, reduced hospital stays, and fewer complications. Bioabsorbable stents perfectly align with this trend, as they reduce the need for follow-up surgeries and minimize long-term health risks.
Key Market Opportunities
Expansion in Emerging Markets: As healthcare access improves in developing countries, there is significant potential for bioabsorbable stents to become a key treatment option. The Asia Pacific region, in particular, is seeing rapid growth in healthcare infrastructure and increasing awareness about cardiovascular diseases, presenting substantial growth opportunities.
Integration of Advanced Drug-Eluting Technology: The development of bioabsorbable stents that are combined with drug-eluting properties presents an opportunity for enhanced patient outcomes. These stents help prevent restenosis (re-narrowing of the artery) and reduce the risk of thrombosis, offering a competitive advantage in the market.
Growing Focus on Personalized Medicine: As healthcare moves toward more personalized treatment options, bioabsorbable stents can be customized for individual patients based on their unique vascular conditions. This shift toward personalized solutions opens up new market avenues for bioabsorbable stents.
Market Segmentation
By Product:
- Coronary Stents:
- Polymer-Based Stents
- Metal-Based Stents
- Peripheral Stents:
- Polymer-Based Stents
- Metal-Based Stents
- Coronary Stents:
By Material:
- Polymer-Based Stents:
- Natural Polymer Stents
- Synthetic Polymer Stents
- Others
- Metal-Based Stents:
- Stainless Steel Stents
- Titanium Stents
- Others
- Polymer-Based Stents:
By Absorption Rate:
- Slow-absorption Stents
- Fast-absorption Stents
By Application:
- Coronary Artery Disease:
- Acute Coronary Syndrome
- Stable Angina
- Others
- Peripheral Artery Disease:
- Lower Extremity Arterial Disease
- Renal Artery Stenosis
- Others
- Others
- Coronary Artery Disease:
By End-User:
- Hospitals:
- Public Hospitals
- Private Hospitals
- Cardiac Centers
- Ambulatory Surgical Centers
- Hospitals:
For more detailed segmentation analysis, visit https://straitsresearch.com/report/bioabsorbable-stents-market/segmentation
Key Players in the Bioabsorbable Stents Market
- Abbott
- Boston Scientific Corporation
- Biotronik SE & Co. KG
- Elixir Medical Corporation
- Medtronic plc
- Terumo Corporation
- Reva Medical, LLC
- Amaranth Medical, Inc.
- Arterial Remodeling Technologies
- Kyoto Medical Planning Co., Ltd.
- Lepu Medical Technology
- Lifetech Scientific Corporation
- Meril Life Sciences Pvt. Ltd.
- ICON Interventional Systems
- OrbusNeich Medical
Regional Insights
Dominated Region: North America is currently the dominant region in the bioabsorbable stents market. The region benefits from advanced healthcare infrastructure, high adoption rates of minimally invasive procedures, and a strong presence of key players in the market.
Fastest Growing Region: Asia Pacific is expected to witness the fastest growth during the forecast period, driven by a rapidly improving healthcare landscape, increasing awareness about cardiovascular diseases, and expanding access to advanced medical treatments.
For more information or to make a purchase before buying, visit https://straitsresearch.com/buy-now/bioabsorbable-stents-market
Conclusion
The global bioabsorbable stents market is positioned for substantial growth, driven by technological advancements, increasing demand for minimally invasive procedures, and rising healthcare investments. The potential for bioabsorbable stents to revolutionize the treatment of cardiovascular diseases presents ample opportunities for both existing players and new entrants in the market. With continuous innovation and a growing focus on personalized healthcare solutions, bioabsorbable stents are poised to become a mainstream option for patients globally.
About Straits Research
Straits Research is a leading market research and consulting firm that delivers actionable insights and in-depth analysis across various industries. Specializing in healthcare, technology, consumer goods, and more, Straits Research enables businesses to make informed decisions and achieve sustained growth. Our expert team provides comprehensive reports and customized solutions that help clients navigate market challenges and identify opportunities for success.
